This Viewpoint discusses the case of Charlie Gard, a young boy with severe mitochondrial disease on life support in the United Kingdom, and the issues at stake in the conflict between his parents’ wishes to pursue expensive, unproven treatment and the UK National Health Service’s insistence on a palliative approach.